IRIS UniCatt

Pagano, Livio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.198
AS - Asia 11.199
EU - Europa 10.853
SA - Sud America 2.244
AF - Africa 302
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 9
Totale 38.828
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.784
SG - Singapore 5.193
DE - Germania 3.638
CN - Cina 2.739
BR - Brasile 1.817
SE - Svezia 1.530
IT - Italia 1.256
FR - Francia 930
VN - Vietnam 860
UA - Ucraina 841
IE - Irlanda 535
IN - India 500
GB - Regno Unito 451
NL - Olanda 451
ID - Indonesia 366
RU - Federazione Russa 306
FI - Finlandia 291
JP - Giappone 244
PL - Polonia 234
HK - Hong Kong 206
TR - Turchia 183
BD - Bangladesh 178
CA - Canada 164
IQ - Iraq 160
AR - Argentina 146
MX - Messico 146
ES - Italia 81
KR - Corea 80
ZA - Sudafrica 75
PK - Pakistan 73
AT - Austria 67
SA - Arabia Saudita 65
EC - Ecuador 64
VE - Venezuela 51
CO - Colombia 49
BE - Belgio 46
EG - Egitto 46
CL - Cile 39
JO - Giordania 39
KE - Kenya 36
MA - Marocco 34
UZ - Uzbekistan 34
IL - Israele 32
AE - Emirati Arabi Uniti 27
CZ - Repubblica Ceca 26
KZ - Kazakistan 25
RO - Romania 25
CI - Costa d'Avorio 24
PY - Paraguay 24
LT - Lituania 23
PH - Filippine 23
JM - Giamaica 22
PE - Perù 20
AU - Australia 19
MY - Malesia 19
AZ - Azerbaigian 17
CH - Svizzera 17
IR - Iran 17
TH - Thailandia 16
TN - Tunisia 16
BO - Bolivia 15
CR - Costa Rica 15
DZ - Algeria 15
UY - Uruguay 15
NP - Nepal 14
AL - Albania 11
ET - Etiopia 11
GR - Grecia 11
MD - Moldavia 11
NG - Nigeria 11
PS - Palestinian Territory 11
DO - Repubblica Dominicana 10
HU - Ungheria 10
OM - Oman 10
AM - Armenia 9
BH - Bahrain 9
HN - Honduras 9
LV - Lettonia 8
PA - Panama 8
TT - Trinidad e Tobago 8
AO - Angola 7
DK - Danimarca 7
EU - Europa 7
SN - Senegal 7
BG - Bulgaria 6
GT - Guatemala 6
HR - Croazia 6
LY - Libia 6
NI - Nicaragua 6
BB - Barbados 5
BY - Bielorussia 5
GE - Georgia 5
KG - Kirghizistan 5
LA - Repubblica Popolare Democratica del Laos 5
LB - Libano 5
NO - Norvegia 5
PR - Porto Rico 5
QA - Qatar 5
LK - Sri Lanka 4
TW - Taiwan 4
Totale 38.752
Salva come PNG Salva come JPEG
Città #
Singapore 2.609
Chandler 1.635
Ashburn 1.559
San Jose 1.469
Jacksonville 532
Dublin 525
Beijing 450
San Mateo 403
Amsterdam 373
New York 355
Jakarta 337
Los Angeles 330
Lauterbourg 317
Ann Arbor 312
Ho Chi Minh City 309
Hefei 306
Frankfurt am Main 302
Wilmington 289
Nanjing 278
Milan 241
Chicago 230
Hanoi 221
Dearborn 220
Tokyo 210
Boston 206
Munich 202
Houston 198
Rome 196
Hyderabad 191
Warsaw 191
Hong Kong 190
Nürnberg 186
Moscow 185
Woodbridge 184
Lawrence 170
São Paulo 166
Buffalo 163
Bremen 158
Hangzhou 158
Dallas 155
St Louis 149
Cattolica 129
Zhengzhou 117
Santa Clara 111
Princeton 103
Boardman 98
Seattle 95
Council Bluffs 93
The Dalles 93
Marseille 92
Nanchang 91
Redwood City 88
Kent 83
Izmir 81
Fairfield 79
Seoul 75
Shanghai 73
Nuremberg 70
Redmond 69
Paris 63
Rio de Janeiro 63
Shenyang 61
Tianjin 61
Mountain View 60
Orem 60
Baghdad 59
Hebei 58
Kunming 53
Toronto 53
Lancaster 52
Brooklyn 49
Mexico City 45
Norwalk 45
Brussels 44
Changsha 44
University Park 43
Helsinki 42
Jiaxing 42
Memphis 42
Philadelphia 42
Belo Horizonte 41
Guangzhou 41
London 40
Phoenix 40
Atlanta 39
Da Nang 39
Washington 39
Amman 36
Montreal 36
Chennai 35
Leawood 35
Cambridge 33
Dhaka 33
San Francisco 32
Haiphong 31
Nairobi 31
Poplar 31
Turku 31
Brasília 30
Düsseldorf 30
Totale 20.284
Salva come PNG Salva come JPEG
Nome #
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 587
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 435
Incidence of acute myeloid leukemia after breast cancer 384
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 382
Factors associated with mortality in bacteremic patients with hematologic malignancies. 374
Factors associated with mortality in bacteremic patients with haematologic malignancies 356
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 354
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort 340
A prospective survey of febrile events in hematological malignancies 307
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 281
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature 267
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 236
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 233
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 228
Factors associated with mortality in bacteremic patients with hematologic malignancies. 218
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 211
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 211
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 198
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 196
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 194
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 193
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 190
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 185
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 184
Epigenetic changes in therapy-related MDS/AML 183
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 183
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 183
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 176
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 174
Similarities and differences between therapy-related and elderly acute myeloid leukemia 171
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 170
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 169
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 167
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 167
Primary plasma cell leukemia followed by testicular plasmacytoma 165
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 164
Hyperleukocytosis and leukostasis: management of a medical emergency 162
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 161
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 159
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients 159
Serum beta 2 microglobulin in psoriasis and psoriatic patients 158
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 158
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. 156
A prospective survey of febrile events in hematological malignancies 156
Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia 155
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 154
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 153
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 152
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 152
Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency 152
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 152
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies 151
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 150
A prospective survey of febrile events in hematological malignancies 149
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 149
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 149
Advanced mast cell disease: an Italian Hematological Multicenter experience. 148
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 148
Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection 147
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study 147
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party 147
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 146
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 146
Hyperleukocytosis and leukostasis: management of a medical emergency 146
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis 145
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 145
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 144
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 144
A patient with acute myeloid leukemia and a solid mass in the colon. 142
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) 142
Tunneling Schmorl?s Nodes in an Elderly Woman Treated for Acute Lymphoblastic Leukemia. 139
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 139
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry 138
Outcome of therapy-related myeloid neoplasms treated with azacitidine 138
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 137
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 137
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107) 136
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 136
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 136
In vitro susceptibility of Candida species isolated from patients with haematological malignancies 135
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders 135
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 134
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 134
Uncommon yeast infections in hematological patients: from diagnosis to treatment 133
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 132
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 132
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 132
First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia 132
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 131
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 131
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients 130
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 129
High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. 128
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 128
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 125
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? 124
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches 124
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) 123
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 123
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 123
Totale 17.894
Salva come PNG Salva come JPEG
Categoria #
all - tutte 165.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.955
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 0 0 0 0 0 27
2021/20222.205 260 151 34 88 149 76 33 334 115 156 332 477
2022/20234.610 525 562 397 773 365 588 167 373 561 94 158 47
2023/20242.512 126 738 92 81 95 351 203 51 36 91 302 346
2024/20255.995 168 166 398 190 445 150 228 265 960 651 1.360 1.014
2025/202614.910 2.189 373 866 1.469 2.359 1.279 2.359 759 991 1.135 487 644
Totale 39.329